Literature DB >> 33070258

CircRNA TGFBR2/MiR-25-3p/TWIST1 axis regulates osteoblast differentiation of human aortic valve interstitial cells.

Cheng Yu1, Dannan Wu2, Chong Zhao3, Chaoguang Wu4.   

Abstract

INTRODUCTION: Calcified aortic valve disease (CAVD) is characterized by valve thickening and calcification. Osteoblast differentiation is one of the key steps of valve calcification. CircRNAs is involved in osteogenic differentiation of multiple mesenchymal cells. However, the function of circRNA TGFBR2 (TGFBR2) in CAVD remained unclear. We explored the effect and mechanism of TGFBR2 in modulating CAVD.
MATERIALS AND METHODS: Human aortic valve interstitial cells (VICs) were subjected to osteogenic induction, and transfected with TGFBR2, miR-25-3p mimic and siTWIST1. The relationship between miR-25-3p and GFBR2 was predicted by starBase and confirmed by luciferase reporter and Person's correlation test. The relationship between miR-25-3p and TWIST1 was predicted by TargetScan and confirmed by luciferase reporter assay. The expressions of TGFBR2, miR-25-3p, TWIST1, osteoblast markers (RUNX2 and OPN) were detected by Western blot or/and qRT-PCR. Alkaline phosphatase (ALP) activity and calcium nodule was determined by colorimetric method and Alizarin Red S staining.
RESULTS: The expression of TGFBR2 was down-regulated and that of miR-25-3p was up-regulated in calcific valves and osteogenic VICs. TGFBR2 was inversely correlated with miR-25-3p expression in calcific valves. TGFBR2 sponged miR-25-3p to regulate TWIST1 expression in osteogenic VICs. During osteogenic differentiation, ALP activity, calcium nodule, the levels of osteoblast markers were increased in VICs. MiR-25-3p overexpression or TWIST1 knockdown reversed the inhibitory effect of TGFBR2 overexpression on ALP activity, calcium nodule, the expressions of RUNX2 and OPN in osteogenic VICs.
CONCLUSION: The findings indicated that TGFBR2/miR-25-3p/TWIST1 axis regulates osteoblast differentiation in VICs, supporting the fact that TGFBR2 is a miRNA sponge in CAVD.

Entities:  

Keywords:  Calcific aortic valve disease; CircRNA TGFBR2; Osteoblast differentiation; TWIST1; miR-25-3p

Mesh:

Substances:

Year:  2020        PMID: 33070258     DOI: 10.1007/s00774-020-01164-4

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  49 in total

1.  Tgfbr2 is required in osterix expressing cells for postnatal skeletal development.

Authors:  Sarah B Peters; Ying Wang; Rosa Serra
Journal:  Bone       Date:  2016-12-30       Impact factor: 4.398

2.  Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis.

Authors:  Wei Li; Qingle Li; Yang Jiao; Lingfeng Qin; Rahmat Ali; Jing Zhou; Jacopo Ferruzzi; Richard W Kim; Arnar Geirsson; Harry C Dietz; Stefan Offermanns; Jay D Humphrey; George Tellides
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

3.  GDF15 induced apoptosis and cytotoxicity in A549 cells depends on TGFBR2 expression.

Authors:  Ghorban Ali Tarfiei; Amir Shadboorestan; Hamed Montazeri; Narges Rahmanian; Gholamreza Tavosi; Mohammad Hossein Ghahremani
Journal:  Cell Biochem Funct       Date:  2019-06-07       Impact factor: 3.685

Review 4.  Aortic-valve stenosis--from patients at risk to severe valve obstruction.

Authors:  Catherine M Otto; Bernard Prendergast
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

Review 5.  CircRNAs: a regulator of cellular stress.

Authors:  Joseph W Fischer; Anthony K L Leung
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-01-17       Impact factor: 8.250

Review 6.  Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.

Authors:  Katherine E Yutzey; Linda L Demer; Simon C Body; Gordon S Huggins; Dwight A Towler; Cecilia M Giachelli; Marion A Hofmann-Bowman; Douglas P Mortlock; Melissa B Rogers; Mehran M Sadeghi; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09-04       Impact factor: 8.311

7.  A TGFBR2/SMAD2/DNMT1/miR-145 negative regulatory loop is responsible for LPS-induced sepsis.

Authors:  Fubing Ma; Zhen Li; Jing Cao; Xiangqing Kong; Guangping Gong
Journal:  Biomed Pharmacother       Date:  2019-02-20       Impact factor: 6.529

8.  Insulin-like growth factor 1 promotes the proliferation and committed differentiation of human dental pulp stem cells through MAPK pathways.

Authors:  Taohong Lv; Yongzheng Wu; Chao Mu; Genxia Liu; Ming Yan; Xiangqin Xu; Huayin Wu; Jinyin Du; Jinhua Yu; Jinquan Mu
Journal:  Arch Oral Biol       Date:  2016-08-20       Impact factor: 2.633

Review 9.  Calcific Aortic Valve Disease: a Developmental Biology Perspective.

Authors:  Punashi Dutta; Joy Lincoln
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

10.  Functional Analysis of preA in Aeromonas veronii TH0426 Reveals a Key Role in the Regulation of Virulence and Resistance to Oxidative Stress.

Authors:  Bintong Yang; Haichao Song; Dingjie An; Dongxing Zhang; Sayed Haidar Abbas Raza; Guiqin Wang; Xiaofeng Shan; Aidong Qian; Yuanhuan Kang; Chunfeng Wang
Journal:  Int J Mol Sci       Date:  2019-12-21       Impact factor: 5.923

View more
  5 in total

1.  circ-CCND1 regulates the CCND1/P53/P21 pathway through sponging miR-138-5p in valve interstitial cells to aggravate aortic valve calcification.

Authors:  Fei Yan; Xiang Xie; Qiang Huo; Weimin Zhang; Tingting Wu; Lin Shi
Journal:  J Physiol Biochem       Date:  2022-07-01       Impact factor: 5.080

Review 2.  Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.

Authors:  Yuncong Shi; Huanji Zhang; Suli Huang; Li Yin; Feng Wang; Pei Luo; Hui Huang
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

Review 3.  Emerging Roles of Extracellular Vesicle-Delivered Circular RNAs in Atherosclerosis.

Authors:  Cheng Wen; Bowei Li; Lei Nie; Ling Mao; Yuanpeng Xia
Journal:  Front Cell Dev Biol       Date:  2022-04-04

Review 4.  Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects.

Authors:  Ma'mon M Hatmal; Mohammad A I Al-Hatamleh; Amin N Olaimat; Walhan Alshaer; Hanan Hasan; Khaled A Albakri; Enas Alkhafaji; Nada N Issa; Murad A Al-Holy; Salim M Abderrahman; Atiyeh M Abdallah; Rohimah Mohamud
Journal:  Biomedicines       Date:  2022-05-24

5.  Hsa_circ_0000437 upregulates and promotes disease progression in rheumatic valvular heart disease.

Authors:  Linwen Zhu; Zhifang Wang; Lebo Sun; Dawei Zheng; Bingchuan Hu; Ni Li; Guofeng Shao
Journal:  J Clin Lab Anal       Date:  2021-12-24       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.